He T - Search Results

1

TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4⁺Foxp3⁺ regulatory T cells.

He T, Chen Y, Yang D, Islam MS, Chou CK, Liu J, Faustman DL, Oppenheim JJ, Chen X. He T, et al. Cell Oncol (Dordr). 2023 Feb;46(1):167-177. doi: 10.1007/s13402-022-00742-0. Epub 2022 Nov 12. Cell Oncol (Dordr). 2023. PMID: 36369606

2

Deficiency in Fpr2 results in reduced numbers of Lin^-cKit⁺Sca1⁺ myeloid progenitor cells.

Chen K, Tang P, Bao Z, He T, Xiang Y, Gong W, Yoshimura T, Le Y, Tessarollo L, Chen X, Wang JM. Chen K, et al. Among authors: he t. J Biol Chem. 2018 Aug 31;293(35):13452-13463. doi: 10.1074/jbc.RA118.002683. Epub 2018 Jul 17. J Biol Chem. 2018. PMID: 30018139 Free PMC article.

3

The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4⁺Foxp3⁺ Regulatory T Cells.

He T, Liu S, Chen S, Ye J, Wu X, Bian Z, Chen X. He T, et al. Front Immunol. 2018 Jul 9;9:1556. doi: 10.3389/fimmu.2018.01556. eCollection 2018. Front Immunol. 2018. PMID: 30038619 Free PMC article.

4

Tetrandrine inhibits differentiation of proinflammatory subsets of T helper cells but spares de novo differentiation of iTreg cells.

Zou H, He T, Chen X. Zou H, et al. Among authors: he t. Int Immunopharmacol. 2019 Apr;69:307-312. doi: 10.1016/j.intimp.2019.01.040. Epub 2019 Feb 12. Int Immunopharmacol. 2019. PMID: 30769211

5

Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4⁺Foxp3⁺ regulatory T cells.

He T, Yang D, Li XQ, Jiang M, Islam MS, Chen S, Chen Y, Yang Y, Chou CK, Trivett AL, Oppenheim JJ, Chen X. He T, et al. Sci Adv. 2020 Sep 30;6(40):eaba6584. doi: 10.1126/sciadv.aba6584. Print 2020 Sep. Sci Adv. 2020. PMID: 32998896 Free PMC article.

6

Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4⁺Foxp3⁺ Regulatory T Cells and Alleviates Imiquimod-Induced Psoriasis in Mice.

Chen S, Lin Z, He T, Islam MS, Xi L, Liao P, Yang Y, Zheng Y, Chen X. Chen S, et al. Among authors: he t. Front Immunol. 2022 Apr 6;13:800283. doi: 10.3389/fimmu.2022.800283. eCollection 2022. Front Immunol. 2022. PMID: 35464441 Free PMC article.

7

Signaling pathway(s) of TNFR2 required for the immunoregulatory effect of CD4⁺Foxp3⁺ regulatory T cells.

He T, Zhao Y, Zhao P, Zhao L, Zakaria J, Wang K. He T, et al. Int Immunopharmacol. 2022 Jul;108:108823. doi: 10.1016/j.intimp.2022.108823. Epub 2022 May 25. Int Immunopharmacol. 2022. PMID: 35623290 Review.

8

Correction: Deficiency in Fpr2 results in reduced numbers of Lin^- cKit⁺ Sca1⁺ myeloid progenitor cells.

Chen K, Tang P, Bao Z, He T, Xiang Y, Gong W, Yoshimura T, Le Y, Tessarollo L, Chen X, Wang JM. Chen K, et al. Among authors: he t. J Biol Chem. 2018 Oct 19;293(42):16175. doi: 10.1074/jbc.AAC118.005966. J Biol Chem. 2018. PMID: 30341215 Free PMC article. No abstract available.

9

TRIP13: A promising cancer immunotherapy target.

Jing S, Zhao L, Zhao L, Gao YJ, He T. Jing S, et al. Among authors: he t. Cancer Innov. 2024 Oct 11;3(6):e147. doi: 10.1002/cai2.147. eCollection 2024 Dec. Cancer Innov. 2024. PMID: 39398261 Free PMC article. Review.

10

Circ_SAR1A regulates the malignant behavior of lung cancer cells via the miR-21-5p/TXNIP axis.

Zhao Y, Wan Y, He T. Zhao Y, et al. Among authors: he t. J Clin Lab Anal. 2022 May;36(5):e24366. doi: 10.1002/jcla.24366. Epub 2022 Mar 25. J Clin Lab Anal. 2022. PMID: 35334496 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,500 results

Search Page

Filters